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and proposed packages of care
Zohra S Lassi, Rohail Kumar, Tarab Mansoor, Rehana A Salam, Jai K Das, Zulfiqar A Bhutta*
Abstract
In an effort to accelerate progress towards achieving Millennium Development Goal (MDG) 4 and 5, provision of
essential reproductive, maternal, newborn and child health (RMNCH) interventions is being considered. Not only
should a state-of-the-art approach be taken for services delivered to the mother, neonate and to the child, but
services must also be deployed across the household to hospital continuum of care approach and in the form of
packages. The paper proposed several packages for improved maternal, newborn and child health that can be
delivered across RMNCH continuum of care. These packages include: supportive care package for women to
promote awareness related to healthy pre-pregnancy and pregnancy interventions; nutritional support package for
mother to improve supplementation of essential nutrients and micronutrients; antenatal care package to detect,
treat and manage infectious and noninfectious diseases and promote immunization; high risk care package to
manage preeclampsia and eclampsia in pregnancy; childbirth package to promote support during labor and
importance of skilled birth attendance during labor; essential newborn care package to support healthy newborn
care practices; and child health care package to prevent and manage infections. This paper further discussed the
implementation strategies for employing these interventions at scale.
Essential interventions for maternal, neonatal and
child health
Considering the interdependent relationship between
maternal, neonatal and child health (MNCH), approaching
essential interventions that have an impact on MNCH ser-
vices has great potential for accelerating progress towards
Millennium Development Goals (MDG) 4 and 5. The inte-
gration of these interventions needs to span not only in
time period (pre-pregnancy, pregnancy, childbirth, and the
postnatal period) but also across the levels of care (com-
munity, primary and referral). The delivery of these essen-
tial interventions can have profound translational and
intergenerational impacts with important implications for
the long-term well-being of mother, newborns and chil-
dren. This can also promote greater efficiency by maximiz-
ing synergies and avoiding duplication of services that are
less efficient if delivered individually. For example, the use
of community based intervention packages have been
shown to reduce maternal mortality, perinatal mortality,
stillbirths and neonatal mortality [1]. Similarly, nutritional
interventions for women prior to conception, such as folic
acid supplementation, have long-term health benefits for
the woman and can also promote healthier development
of the fetus [2].
Pregnancy itself also represents a key window of oppor-
tunity for synergistic impact. For example, vaccination of
the mother against tetanus during pregnancy can prevent
neonatal tetanus and death associated with neonatal teta-
nus. During the most high-risk stage, i.e. delivery, these
interventions is crucial and can have a profound impact on
reducing maternal and neonatal mortalities. Skilled birth
attendance can avert or manage the most common causes
of mortality for both mothers and newborns, namely
hemorrhage and complications arising from prematurity/
low birth weight (LBW), respectively. A skilled birth atten-
dant with the proper training and equipment can both
manage excessive bleeding of the mother and also provide
neonatal resuscitation. Further along the continuum of
MNCH care, services during the postnatal period, such as
early breastfeeding initiation, vaccinations, postnatal visits,
and home based care can together have a profound impact
on bolstering the health of the mother and neonate.
This paper summarizes essential interventions (table 1)
which have been shown to have an impact on improving
MNCH outcomes and could be used by both clinicians* Correspondence: zulfiqar.bhutta@aku.eduDivision of Women and Child Health, Aga Khan University, Karachi, Pakistan
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Table 1 Essential reproductive, maternal, newborn and child health interventions
Priority interventions Level of
care
Health care cadre Key commodities
Preconception/periconceptual interventions
Family planning [46-49] Community
Primary
Referral
All • Barrier methods (male and female
• Condoms, diaphragm, gels, foams)
• Oral contraceptives (progestin only and
combined)






• All of the above plus implants
• Long acting reversiblecontraceptives (implants)
• Intrauterine devices
• Surgical contraception
Prevention and management of sexually transmitted infections
(STIs), including HIV for prevention of mother to child




All • Materials for counselling
• Condoms (male and female)






• Materials for counselling
• Condoms (male and female)
• Antibiotics in line with essential medicine
guidelines
• Laboratory test kits for STI/HIV
• Anti-retroviral medicines (refer to the essential
list of medicines)
Folic acid fortification and/or supplementation to prevent




All • Folic acid fortification of staple food e.g. flour
















All • Iron and folic acid





All • Vaccine (TT vaccine)
Prevention and management of malaria in pregnancy
a) Prophylactic antimalarial for preventing malaria in pregnancy
[8,9]
b) Provision and promotion of use of insecticide treated nets




All a) Antimalarial drugs according to the situation/
context
b) Insecticide treated nets
Interventions for smoking cessation during pregnancy for




All • Materials for individual and group counselling
and behavioural change interventions on
smoking cessation




• Onsite tests and laboratory equipment
• Penicillin
• Counselling material
Prevention and management of HIV and prevention of mother




All • HIV test kits
• Antiretroviral drugs
• Cotrimoxazole
Prevention and management of hypertension in
pregnancy
a) Calcium supplementation in pregnancy [22-24]
b) Low-dose Aspirin for the prevention of pre-eclampsia in
high risk women [24,57,58]
c) Use of antihypertensive drugs for treating severe
hypertension in pregnancy [59,60]



















b) Low dose aspirin
c) Methyldopa, hydralazine, nifedipine
d) Magnesium sulphate (Injection)
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Table 1 Essential reproductive, maternal, newborn and child health interventions (Continued)
Management of prelabour rupture of membranes and preterm
labour:
A) Induction of labour for management of prelabour rupture of
membranes at term [51]
Referral Professional health
workers
• Uterotonic (oxytocin and/or misoprostol)
• Partograph
• Stethoscope















Management of unintended pregnancy: [68]
a) Availability and provision of safe abortion when indicated
and legally permitted





• Materials for counselling, health education and
health promotion
• Medications for induced abortion
(mifepristone, misoprostol)
• Vacuum aspiration equipment
• Uterotonics (misoprostol, oxytocin)
• Antibiotics in line with essential medicine
guidelines
• Surgical procedures when required
Childbirth




Prophylactic antibiotic for caesarean-section [71] Referral Professional health
workers
• Antibiotics (ampicillin or cefazolin)
Prevention of postpartum haemorrhage





All • Uterotonics (oxytocin, misoprostol)






• Uterotonics (oxytocin, ergometrine)
Induction of labour for prolonged pregnancy [78,79] Referral Professional health
workers
• Uterotonics (oxytocin, misoprostol)
Caesarean section for absolute maternal indication (e.g.




Management of post-partum haemorrhage e.g.:
a) Uterine massage [102]
b) Uterotonics [35,103]














Advice and provision of family planning [104] Community
Primary
Referral
All • Barrier methods (male and female condoms,
diaphragm, gels, foams)
• Oral contraceptives (progestin only and
combined)
• Long acting reversible contraceptives




Prevent, measure and treat maternal anaemia [105] Referral Professional health
workers
• Ferrous salt (liquid or tablet)
• Ferrous salt + folic acid (tablet)





Detection and management of postpartum sepsis [106] Referral Professional health
workers
• Antibiotics (ampilcillin, gentamicin,
metronidazole)




Professional • Antiretroviral medicines
Birth and postnatal – newborn
Immediate essential newborn care (at the time of birth)
Promotion and provision of thermal care for all newborns to





All • Materials for counselling, health education and
health promotion
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Table 1 Essential reproductive, maternal, newborn and child health interventions (Continued)
Promotion and support for early initiation and exclusive




All • Materials for counselling, health education and
health promotion





All • Cord clamp and scissors
• Clean birth kit for health facilities
Neonatal resuscitation with bag and mask for babies who do






• Training aids and devices to maintain
competencies
• Newborn resuscitation device (Ambu Bag,





• Vaccines, syringes, safety boxes, cold chain
equipment
Neonatal infection management




• Antibiotics (ampicillin and gentamycin or
penicillin)







• Materials for counselling, health education and
health promotion
• Thermometer / digital thermometer
• Timer
• Blood sugar sticks (disposable)
• Nasogastric tube
• Antibiotics (oral and injectable)






• Materials for counselling, health education and
health promotion
• Support Binder for KMC (KMC wrap)
• Hat
• Nasogastric tube








• Blood sugar testing sticks
• Materials for counselling
Prophylactic and therapeutic use of surfactant to prevent
respiratory distress syndrome in pre-term babies [83-85]
Referral Professional health
workers
• Surfactant (await generics)
• Oxygen supply/concentrator
• Pulse oximeter
Continuous positive airway pressure (CPAP) to manage pre-
term babies with respiratory distress syndrome [80-82]
Referral Professional health
workers
• Standard CPAP or bubble CPAP
• Oxygen supply/concentrator
• Pulse oximeter








• Exchange transfusion kit
Infancy and childhood





All • Materials for counselling, health education and
health promotion, including individual and
group counselling
Promotion and support of continued breastfeeding and
complementary feeding
a) Continued breastfeeding up to 2 years and beyond [122]





All • Materials for counselling, health education and
health promotion
Prevention and management of childhood malaria
a) Provision and promotion of use of insecticide treated bed
nets for children [11]




All • Materials for counselling, health education and
health promotion
• Insecticide treated nets
• Rapid diagnostic tests
• Antimalarial drugs according to guidelines
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and policy makers in low and middle income countries
(LMICs) programs. The paper further proposes packages
of evidence-based effective interventions and strategies for
delivery for such packages in varying contexts. Some inter-
ventions require technical expertise (e.g. management of
eclampsia), whereas others can be provided at the commu-
nity level (e.g. counseling for immediate and exclusive
breastfeeding). Building on the evidence reviewed in this
paper, the following essential interventions (refer to the
link: http://www.who.int/pmnch/topics/part_publications/
essential_interventions_18_01_2012.pdf) suggest a way
forward in integrating and packaging MNCH across the
continuum of care.
Summary of essential interventions applicable at
all levels: community, primary, and referral
Infectious diseases and immunization
HIV and sexually transmitted infections (STI)
Mass treatment and behavioral interventions to increase
awareness can non-significantly reduce the incidence of
STIs and HIV [3-6]. Antiretroviral therapy (ARV) given
in order to reduce the transmission of HIV showed that
short courses of ARV drugs are effective in reducing
transmission [7]. It was noted giving either the combina-
tion of zidovudine (ZDV) and lamivudine (3TC) to
mothers during antenatal, intrapartum and postpartum
period and to babies for a week after delivery or a single
dose of nevirapine (NVP) given to mothers in labor and
babies immediately after birth may be most effective in
reducing the rates of vertical transmission [7].
Malaria
Antimalarial drugs reduce antenatal parasitemia when
given to pregnant women in malarial endemic areas with
greater benefit is seen in primi- and secundi-gravidas [8].
Sulfadoxine-pyrimethamine regimen is feasible, though
their regular use may precipitate increased risk of resis-
tance. It is also associated with lower incidence of LBW
(35%) and all-cause child mortality (18%) [9]. The evidence
showed increased protective efficacy of artemisinin-based
combination therapies for treating uncomplicated malaria
[10]. Effective case management of malaria including par-
enteral quinine for treating severe P. falciparum malaria
also displayed protective impact on malaria mortality in
children under five [11].
The use of insecticide treated nets (ITNs) is very effec-
tive in reducing perinatal morbidity and mortality [11].
Table 1 Essential reproductive, maternal, newborn and child health interventions (Continued)
Promote and provide routine immunization plus H.influenzae,





All • Materials for counseling, health education and
health promotion
• Vaccines, syringes, safety boxes, cold chain
equipment





All • Vitamin A capsules
• Material for counselling on Vitamin A rich
foods
Management of severe acute malnutrition: [28,134]
a) Without complications (All levels)





• Appropriate ready-to-use therapeutic foods
• Micronutrient supplements
• Vitamin A capsules
Health facility level
• Antibiotics
• Therapeutic food formulations (F75/100)
Case management of childhood pneumonia [15,135-137]
a) Vitamin A as part of treatment for measles-associated
pneumonia for children above 6 months [25,26]
b) Vitamin A as part of treatment for non-measles-associated





• Respiratory rate timers




• Oxygen for severe pneumonia
• Pulse oximeter
Case management of diarrhoea:





All • Materials for counselling, health education and
health promotion
• Zinc (tablets / solution)
• ORS
• Appropriate antibiotics for dysentery
according to guidelines





Home visits across the continuum of care women’s groups
[1,86,87,150,151]
Community All • Material for counselling, health education and
health promotion
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It reduces peripheral and placental parasitemia, increases
mean birth weight, and decreases the risk of fetal loss in
the women in their first to fourth pregnancies. ITNs there-
fore should be an integral part of strategies to prevent
malaria in pregnant women living especially in areas
where malaria is endemic. There is strong evidence that
ITNs use can reduce child mortality by 18% [11].There is
a need for large-scale implementation of this intervention
in malarial endemic areas.
Immunizations
Efforts are being made to maximize the coverage of
immunization (EPI and EPI plus H influenza, pneumo-
coccal conjugate vaccination, rotavirus) and the newer
vaccines to avoid preventable deaths in women and chil-
dren. Current evidence shows that rhesus rotavirus vac-
cines (particularly RRV-TV) and the human rotavirus
vaccine 89-12 are efficacious in preventing rotavirus
caused diarrhea and all-cause diarrhea [12]. Although,
evidence about safety, or prevention of severe outcomes,
is scarce and inconclusive. The current evidence also
supports the implementation of tetanus immunization in
pregnancy in communities with similar or higher levels
of risk of neonatal tetanus [13,14].
Case management of neonatal and childhood infections
Case management of pneumonia could result in a 35%
reduction in mortality from pneumonia in 0–5-year-old
children [15]. On the basis of available evidences, it can be
concluded that antibiotics have a clear role in reducing
neonatal mortality as a result of meningitis, pneumonia
and sepsis, in low income areas and can be effectively
administered in homes via trained health workers.
Hygienic cord and skin care
Use of antiseptic chlorhexidine is associated with lower
risk of bacterial colonization (with S. aureus, Streptococci
and E. coli), neonatal mortality and omphalitis [16].
Nutritional rehabilitation and micronutrient supplements
Folic acid
Folic acid fortification/supplementation to prevent neural
tube defect (NTD) has a significant protective effect on
NTDs, particularly in women who had a previous preg-
nancy affected by it (recurrent NTDs) [17-19]. Therefore,
all women with a history of baby with NTDs should be
advised and given folic acid to prevent its recurrence. Pro-
viding mothers during pregnancy with folic acid and iron
also reduces the risk of being anemic near or at term.
Iron
Providing mothers during pregnancy with iron reduces the
risk of being anemic near or at term [20,21]. These reviews
suggested that newborn, whose mothers were provided
with iron supplementation during the antenatal period,
showed reduced risk of low birth weight and premature
births.
Calcium
Calcium to prevent hypertension significantly reduces the
risk of pre-eclampsia by 55% and by 64% in women with
low dietary intake of calcium [22]. It also had a signifi-
cant protective effect on maternal mortality and serious
morbidity and preterm birth [22-24].
Vitamin A
Vitamin A supplementation as prevention and treatment
of measles and pneumonia in children after six months
of age reduces all-cause mortality and measles specific
mortality [25,26]. Due to its beneficial effect on all-cause
and diarrhea-specific mortality, routine vitamin A supple-
mentation in this age group has thus been recommended.
Zinc
Therapeutic zinc supplementation has a beneficial effect
on reducing duration and severity of acute and persis-
tent diarrhea [27]. On the basis of these results, it is
proposed that zinc supplementation should especially be
applied to low income countries where the burden of
diarrheal diseases is the highest. In contrast, treatment
of pneumonia episodes with zinc is has shown no bene-
ficial impacts on reducing pneumonia mortality.
Nutritional rehabilitation
Proper implementation of WHO guidelines for manage-
ment of severe acute malnutrition (SAM) can decrease
morality by 61% in hospital setting [28]. Children who
were moderately or severely malnourished show better
weight gain and higher recovery rates with ready-to-use
therapeutic food than other management options such
as F-100 or corn flour diet.
Antenatal and birth care
Continuous social support
Continuous social support has shown significant clinical
benefits for women and infants. Continuous support
was more likely to have a spontaneous vaginal birth
(8%), less likely to have intrapartum analgesia (10%), less
likely to have a caesarean (21%) or instrumental vaginal
birth (10%) [29]. Therefore, it is recommended that all
women should receive continuous social support
throughout labor and childbirth.
Intra and post-partum hemorrhage (PPH)
It was noted that active management is superior to expec-
tant management in terms of reduction in the risk of
maternal hemorrhage at time of birth [30-33]. However,
significant results in the improved outcomes of blood loss
and PPH could not be found when active management
was employed. On the other hand, prophylactic oxytocin
showed benefits in reducing blood loss >500ml and need
for therapeutic oxytocics [34].
Misoprostol when compared with placebo was found to
be effective in reducing severe PPH and blood transfu-
sion [35]. In comparison with conventional injectable
Lassi et al. Reproductive Health 2014, 11(Suppl 1):S5
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uterotonics, oral misoprostol was associated with higher
risk of severe PPH and use of additional uterotonics, but
with a trend to fewer blood transfusions.
Smoking cessation
Smoking cessations in pregnancy have shown to reduce
preterm birth, low birth weight, and bring an increase in
mean birth weight [36,37]. It is important that smoking
cessation programs be implemented in all maternity care
settings.
Neonatal care and breast feeding
Hypothermia
Immediate thermal care is an important delivery care,
leading to fatal morbidities and consequent mortality.
Any intervention other than primary care designed for
prevention of hypothermia, and applied within 10 min-
utes after birth in the delivery suite, may be beneficial in
practice [38]. The interventions include: plastic wraps
and bags, skin-to-skin contact, and transwarmer mat-
tresses etc. These interventions keep infants warmer and
lead to higher temperatures on admission to the NICU
and to decreased incidence of hypothermia. To prevent
the morbidity and mortality in preterm infants due to
hypothermia, consideration should be given to using
these interventions in the delivery suite.
Neonatal resuscitation
Evidence has shown that neonatal resuscitation with bag
and mask has a vital role in saving newborn lives [39-41].
However, the feasibility of scaling up this approach is
unclear. Facility based resuscitation training found reduc-
tions in intrapartum related neonatal mortality; while
community based resuscitation training found reduction
in all cause and asphyxia related neonatal mortality. No
randomized, controlled trials were found to support or
refute that the administration of epinephrine to the appar-
ently stillborn or extremely bradycardic newborn infant
reduces mortality and morbidity. Similarly, we found no
randomized, controlled trials which addressed the issues
of optimum dosage and route of administration of
epinephrine.
Breast feeding and complementary feeding
Individual and group counseling to pregnant mothers
showed an increase in rates of mothers exclusively
breastfeeding in the neonatal period and at six months
[42,43]. Also, group counseling showed better results of
mothers who breastfeed in the neonatal period and at 6
months compared to those mothers who were individu-
ally counseled on the benefits of breastfeeding [44]. Cur-
rent evidence suggests that interventions to promote
complementary feeding have a positive impact on health
outcomes of infants, including stunting and weight gain.
These impacts are significant in both food-secure as well
as insecure populations [45].
Family planning and contraception
Short inter-pregnancy interval (IPIs) is associated with a
higher risk of preterm birth, low birth weight, fetal death
and small for gestational age infants compared to IPIs of
18 - 23 months [46-49]. The risk is also high for these
three adverse outcomes if the infant is conceived 60
months or more after a birth. Therefore family planning
should be advised to plan pregnancies at appropriate
intervals.
Postpartum education about contraception is also found
to improve contraception use and fewer unplanned preg-
nancies [50]. The effectiveness of postpartum education
about contraceptive use has not yet been established in
randomized controlled trials. Such education may be effec-
tive in increasing the short-term use of contraception.




For preterm, premature rupture of membrane (PPROM),
the use of antibiotics was associated with a significant
reduction in chorioamnionitis, preterm birth and neonatal
infections, which would support their routine clinical use
in such cases [51]. It did not, however, significantly impact
perinatal mortality and neonatal mortality.
HIV and STIs
A regimen combining triple ARV is most effective for pre-
venting transmission of HIV from mothers to babies [7].
The risk of adverse events to both mother and baby
appears low in the short-term but the optimal ARV com-
bination and the optimal time to initiate this to maximize
prevention efficacy without compromising the health of
either mother or baby remains unclear.
There is strong evidence for HIV-infected women to
exclusively breastfeed for 6 months, however, the deci-
sion on continued breastfeeding remains unclear and
further evidence is required [52-55]. For children with
HIV infections, the results of the Cochrane review on
co-trimoxazole prophylaxis showed that the children
who received the prophylactic treatment survived longer
and had reduced number of days spent in hospital [52].
The review on antibiotics given for the management of
syphilis did not have any trial that met the eligibility cri-
teria. However, observational studies showed lower inci-
dence of neonatal mortality by 82% and preterm delivery
by 64% [56].
Antenatal care
Hypertension, pre-eclampsia and eclampsia
The results show that when low dose aspirin are given
during pregnancy, it lead to consistent reduction in the
risk of preterm births (less than 34weeks), pre-eclampsia
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and other adverse effect of pregnancy [24,57,58]. Impor-
tantly for the fetus there is a significant reduction of
17% in mortality (fetal, neonatal, and infant). We would
recommend that anti-platelet agents should be given to
pregnant women at high risk of pre-eclampsia or those
with gestational hypertension, since they lead to reduc-
tion of vast adverse outcomes of pregnancy both for the
mother and newborn.
The use of anti-hypertensive causes a reduction in
progression to severe hypertension [59,60]. The impact
on eclampsia and perinatal/neonatal mortality was not
significant; however, oral beta-blockers decrease the risk
of severe hypertension by 63% and the need for addi-
tional antihypertensives by 54%.
Magnesium sulphate is an inexpensive drug and can
be conveniently used in low income countries. The
review indicates that this drug significantly reduces the
progress to eclampsia when given to women with pre-
eclampsia [24,61-64].
Use of corticosteroids
Corticosteroids to prevent RDS in newborn showed a
significant 31% reduction in neonatal deaths (31%).
There was also a significant 34%, 45%, and 46% reduc-
tion in the incidence of RDS, cerebroventricular hemor-
rhage and severe cerebroventricular hemorrhage,
respectively [65-67].
Safe abortions
According to the WHO guidelines, safe abortion ser-
vices, as provided by law, need to be available, provided
by well-trained health personnel supported by policies,
regulations and a health systems infrastructure, includ-
ing equipment and supplies, so that women can have
rapid access to these services [68].
Intra and postpartum care
It was noted that active management of third stage of
labor to prevent postpartum hemorrhage is far superior
to expectant management [30-33]. This was seen with
significant results in the outcomes of blood loss, post-
partum hemorrhage, severe postpartum hemorrhage,
need for blood transfusion and postpartum anemia.
Immediate and essential newborn care
Hypothermia
Evidence synthesized from a number of RCTs shows
that Kangaroo Mother Care (KMC) has a large effect on
mortality and is also effective in reducing morbidity
[69,70]. This evidence is sufficient to recommend the
routine use of KMC in facilities in babies <2000g at
birth. The potential effect of KMC is greatest in low-
income countries, where other options for care of pre-
term babies remain limited with few neonatal care facil-
ities, mainly in distant referral hospitals and those that
are often understaffed and ill-equipped.
Summary of essential interventions at referral
levels only
Infectious diseases
For the prophylactic antibiotic for caesarean section, the
results from Cochrane review concludes that the combi-
nation of clindamycin and an aminoglycoside (such as
gentamicin) is appropriate for the treatment of endome-
tritis, the most common cause of puerperal fever and
sepsis. Prophylactic antibiotic administration in caesar-
ean section was found to reduce endometritis and
wound infections [71].
There are insufficient data from randomized con-
trolled trials to guide clinical practice. A large rando-
mized controlled trial is needed in asymptomatic term
infants born to mothers with risk factors for infection in
their babies, which compares the effect of prophylactic
versus selective antibiotics on morbidity, mortality and
costs.
Intra and postpartum care
Breech presentation
For reducing mal-presentation at term with external
cephalic version, there is sufficient evidence to conclude
that external cephalic version at term reduces the
chances of non-cephalic births and caesarean sections
[72-77].
On the basis of current evidence, it can be con-
cluded that a policy of planned caesarean section
compared with planned vaginal birth, for singleton
term breech presentation, is associated with a decrease
in perinatal or neonatal death and/or neonatal mor-
bidity. Although there is an associated perinatal mor-
bidity, the most relevant outcome is the reduction in
perinatal/neonatal death. This protective benefit out-
weighs the risks associated with caesarean section.
Planned Caesarean section is therefore recommended
for delivery of the baby with breech presentation com-
pared to vaginal delivery.
Prolonged pregnancy
In the case of absence of a specific disorder, induction
of labour can be proposed in patients between 41(+0)
and 42(+6) weeks (grade B) [78,79]. The choice of pro-
longation beyond above 42(+0) weeks appears to involve
an increase in fetal risk. This must be explained to the
patient and balanced against the potential disadvantages
of induction to enable an informed decision. This policy
is associated with fewer deaths (69% perinatal deaths).
There does not seem to be any increased risk of assisted
vaginal or abdominal delivery. If the woman chooses to
wait for spontaneous labor onset it would be prudent to
have regular fetal monitoring as longitudinal epidemio-
logical studies suggest increased risk of perinatal death
by increasing gestational age.
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Small and sick newborn care
Mechanical ventilation for respiratory distress syndrome
(RDS)
Noninvasive positive pressure ventilation (NIPPV) com-
pared to Continuous Positive Airway Pressure (CPAP)
to manage babies with RDS may be a useful method in
preterm infants with apnea [80-82]. The review shows
that there are more benefits in treating neonates with
triggered ventilation compared to conventional ventila-
tion. There was a reduction in both air leaks and dura-
tion of ventilation [80].
Surfactant use
Another important intervention pertaining to preterm
survival is surfactant administration. Infants who under-
went prophylactic administration of synthetic surfactant
had a decreased risk of pneumothorax, pulmonary inter-
stitial emphysema and neonatal mortality [83-85]. Also
infants who were given synthetic surfactant showed an
increased risk of developing patent ductusarteriosus and
pulmonary hemorrhage. Results also show that multiple
doses of surfactant as prevention or treatment resulted
in reduction in the incidence of pneumothorax, mortal-
ity and necrotizing enterocolitis [83-85].
Summary of cross cutting community strategies
The available data suggests that introduction of commu-
nity based intervention packages can improve maternal
and neonate survival [1,86,87]. The results from
Cochrane review are very promising and showed impact
on reducing stillbirths, perinatal mortality and neonatal
mortality [1]. According to available evidence, it is
recommended that home visits should be initiated as
soon as possible after birth or after returning home
from the facilities. A visit within the first 24 hours after
birth is likely to be most effective in reducing newborn
mortality. Additional visits on day 3 and, if possible, on
day 7 can improve home care practices and identify
danger signs or illness. Low birth weight babies need
additional care to survive and stay healthy. This includes
greater support for keeping them warm, initiating early
and exclusive breastfeeding, and preventing infections.
Proposed packages of care
The essential interventions identified in this paper can
be bundled together and delivered in various packages
to increase efficiency and provide a synergistic effect.
These interventions can be bundled into the seven
packages for delivery. In these seven packages of care,
several means of delivery exist, and should be adopted
in a context-specific manner. Critical to the success of
delivering these packages, however, will be the support
of several key players, including community health
workers (CHWs) and professional health workers in
first-level facilities as providers of care. For successful
implementation of these interventions, these cadre of
workers need to be trained. Funding should also be
comprehensive and sustained to deliver these interven-
tions across the household to hospital continuum of
care in affordable and accessible manner.
The interventions within the packages identified are,
to a large extent, low-tech, low-cost, and have been
implemented in an effective manner with strong impact.
These packages should be implemented incrementally,
with close coordination and strengthening of the exist-
ing health system beginning at the community and dis-
trict level. Creation of these packages can also support
in the rationalization of limited resources in a more
effective and evidence-based manner. A similar package
has been proposed earlier for maternal and newborn
interconnected interventions [88]. Therefore, we have
also incorporated interventions in the packages designed
earlier to support their implementation [88]. The seven
proposed packages are as follows and are summarized in
figure 1
1. Supportive care package for women
Supportive care packages for women are crucial for the
wellbeing of both the mother and the child. This pack-
age supports the health of the mother and child during
pregnancy and during the postpartum period through
promoting healthy behaviors and emotions, including
advice and counseling for family planning, smoking ces-
sation, awareness regarding safe sexual practices and
prevention and management of malaria which can be
provided through community based support groups.
These packages should be introduced at all levels of
health care and must be readily available to all the
women who belong to the reproductive health group.
To increase the reach of this particular intervention,
CHWs or outreach workers must be trained to provide
counselling at the community level. These packages
should also exist at the basic health units and the rural
health care centres at the primary level of health care.
On the referral level, health care professionals should be
trained to provide counselling and advice to those seek-
ing it. The package should include important informa-
tion to be dispensed to new mothers or those who plan
to conceive. Women and their partners should be coun-
selled about family planning, different methods and
proper use of contraception, prevention and manage-
ment of malaria in pregnancy and interventions for
smoking cessation during pregnancy for improving birth
outcomes. At the referral level, procedures should be
available for those seeking long term contraception such
as intra-uterine device, tubal ligation, surgical contracep-
tion as well as long acting reversible contraceptives
(implants). Prevention and management of STIs; includ-
ing prevention of mother to child transmission
(PMTCT) of HIV and syphilis by the use provisions
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such as HIV test kits, ARV drugs and cotrimoxazole
should be practiced in all areas with high prevalence of
these diseases.
2. Nutrition support care package for mothers
This package consists of key nutrition interventions,
including periconceptual folic acid supplementation, iron/
folic acid during pregnancy, and calcium supplementation
in pregnant women with low/inadequate calcium intake.
These interventions can be both promoted and delivered
at the community level. Supplementation can also be
administered via outpatient programs. The women should
also be counselled to make changes in their diets to
improve their health status. Folic acid fortification and/or
supplementation to prevent NTDs must be advocated and
Figure 1 Packages for reproductive, maternal, newborn and child health care delivery systems
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use of folic acid fortified staple food can be advised to all
those who are pregnant or plan to conceive in the future.
Iron and folic acid supplementation during pregnancy
should also be advised to those women who show signs of
anaemia. Calcium supplementation in pregnant women
with low/inadequate calcium intake has also been shown
to be beneficial and must be advocated to those in whom
it is justified.
3. Antenatal care package
Antenatal care can be delivered at the primary and out-
patient level. The package must include birth prepared-
ness at the nearest health care centre and availability of
trained birth attendants and sterile surgical equipment,
risk detection by the use of fetal stethoscopes and ultra-
sound, and counselling and health promotion at all
levels of health care in an integrated approach. Equip-
ment such as fetal stethoscope, scale, sphygmoman-
ometer‚ haemoglobin-meter must be available at
primary health care settings. Detection, treatment and
management of maternal risks factors are included in
this package and that includes management of malaria,
HIV and STI infections. The early detection should
result in prompt treatment at the primary of referral
health care centres by a certified medical professional.
Anaemia, pre-eclampsia and nutritional deficiencies in
mothers can be screened at outpatient visits. However, at
the community level, mothers can also be counselled on
the benefits of breastfeeding and newborn care and
health care seeking. It is also important to ensure that
the CHWs have a generally good rapport to improve
compliance and also to be able to detect any risk earlier
through regular scheduled home visits. Few other inter-
ventions such as tetanus immunization during pregnancy
can also be delivered at the level of the community or via
outpatient/outreach programs. It is important to advo-
cate the delivery of the vaccine for the prevention of any
complication arising from lack of immunization.
4. Package for high risk pregnancy
Routine antenatal care can be expanded by adding few
important interventions for women who are at high risk
of pregnancy. These interventions allow management of
pregnancy-induced hypertension (PIH), pre-eclampsia
and eclampsia. These interventions are more appropriate
at the tertiary care level after thorough clinical and
laboratory assessment, but could be adapted for imple-
mentation at lower levels of the health care system. The
availability of Uterotonic (Oxytocin and/or Misoprostol),
partograph for the management of pre mature rupture of
membranes should be ensured to avoid any loss of life
arising due to such complications. Stocks of Calcium,
Low dose Aspirin, Methyldopa, hydralazine, nifedipine,
Magnesium Sulphate (Injection) should be available at
the pharmacy for those who require treatment in primary
as well as referral levels of health care to ensure timely
delivery of these crucial interventions and reduction for
the need to travel long distances to acquire these services.
Health care professionals should also be trained to plan
and manage high risk pregnancy as well as respond to
any emergency that may arise.
5. Childbirth care package
Childbirth care package is crucial to the survival of both
the mother and the neonate in the critical period of
delivery and post-partum. External cephalic version
must be employed by trained health care professionals
to reduce malpresentation, induction of labor for pro-
longed pregnancy, active management of third stage of
labor are few of the interventions that can be delivered
at tertiary level. Adequate sterilization of surgical envir-
onment must be ensured for caesarean section and
instrumental delivery by health care professionals. These
interventions require tertiary level care. These interven-
tions should be considered essential components of any
childbirth care package and includes training of skilled
birth attendance (doctors, nurses, midwives), and tradi-
tional birth attendant (TBAs)for clean delivery and
referral. Another implementation strategy could be the
provision of birth kits to the TBAs will ensure access to
this facility to those residing in remote areas. This will
reduce the mortality incidence that arises from delay in
the provision of emergency medical aid during
childbirth.
6. Essential newborn care package
In the postnatal period, interventions such as breastfeed-
ing, thermal care, kangaroo mother care, skin and cord
care can be provided by CHWs. These interventions can
be integrated into another important postpartum inter-
vention, namely, postnatal visits. At the level of the ter-
tiary care center, postnatal care, particularly for low
birth weight infants and newborns at-risk.
7. Child health care package
Malnutrition and infections carry the greatest brunt of
deaths in children less than 5 years of age. Therefore,
child health support includes nutritional support and
infection management interventions. Exclusive breast-
feeding, complementary feeding and vitamin A supple-
mentation are some of the nutritional interventions that
can be delivered at community level by developing sup-
port groups for women for education and empower-
ment, and training community health workers. Case
management of childhood illness, such as malaria, pneu-
monia and diarrhea can be performed in the outpatient
setting, whereas management of HIV and STIs should
preferably be done at a tertiary care center. Immuniza-
tion for EPI, pneumococcal vaccine and Rota virus vac-
cine are some of the other interventions that can be
delivered at primary or tertiary levels.
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Implementation strategies
Implementation of the health care packages discussed
earlier is the most crucial and important task at hand.
In order to better understand the implementation strate-
gies we have to take into account different hurdles that
have halted the provision of health care. It is vital to
understand the fact that these packages are central for
low income countries where maternal and child health
indicators are still not up to standard. Some of the
known reasons for the poor health indicators in these
areas include low levels of education, poor awareness
regarding health care services, lack of infrastructure to
support health care, deprived sanitation and hygienic
practices, poverty, dearth of access to communities as a
result of armed/political conflicts and poor acceptance
of health care services as a result of cultural and social
practices and beliefs. The implementation strategies thus
have to tackle with these issues in order to successfully
provide the health care package and improve reproduc-
tive, maternal, neonatal and child care outcomes. We
have devised and highlighted the following strategies
that can be useful in such scenarios (see figure 2), how-
ever, it is important to understand that these strategies
are sequential to a large extent but some of the steps
need not follow the others and can be implemented
concurrently.
Allocation of funds and resources
While we have outlined the interventions needed to
improve targeted issues, not every part of the world has
the same problems. It is thus essential to identify the
needs and concerns of a particular area and then allo-
cate resources and funds accordingly. For instance a
community may have a high maternal mortality rate but
a low prevalence of HIV. Here funds should be redir-
ected towards antenatal and intrapartum care rather
than on packages focusing on management of HIV. This
allows a balance and focused approach and improves
health care as needed by the community. Identification
of needs can be accomplished by simple cross sectional
studies, surveys and assessment of the health care
records. Community members can be empowered and
trained to carry out these tasks as well. The collected
data can then be used to gather funds and resources
from government and non-government organizations for
improving health care delivery.
Supporting infrastructure
It is necessary to provide a sustaining infrastructure to
improve RMNCH outcomes. This requires input from
multiple levels especially the NGOs and local authori-
ties. Allocation of funds to important areas of health
care that are responsible for poor outcomes is a neces-
sary step. Provision of primary health care facilities and
availability of trained medical staffs should be empha-
sized upon. In communities, where the access to health
facility is an issue, transport facilities should be pro-
vided. . By supporting infrastructure we can strengthen
the facility care.
Community health workers
Community health workers and TBAs can play a signifi-
cant role in improving maternal and newborn health
care outcomes. Empowering and training people from
within the community and allowing them to address
health care issues can overcome cultural and social
practices and beliefs that do not allow access to health
care. CHWs can not only provide awareness and educa-
tion but also play a significant role in providing case
management of maternal and newborn infections,
immunizations, identification and management of high
risk pregnancies and provision of primary and referral
services. CHWs can provide a much needed bridge
between communities that do not have an access to
health care facilities and health facilities.
Education and awareness
While educating the community about health care needs
has always been emphasized upon, it is also important to
educate health care professionals on the needs and health
care issues of the community. Through courses, seminars
and conferences health care professionals should be
informed about the important health care issues of the
community. They should also be encouraged to participate
in discussions to come up with ideas and solutions for the
problems at hand. This will allow the health care providers
of the community to better understand the problems and
hence allow them to support the people in a much better
way. Awareness regarding packages of health care can also
be created at community level by posters and bill boards in
heavily frequented streets and hospitals. The intervention
can also be implemented by government or NGO funded
advertisement campaigns on radio or television during
prime time to ensure maximum reach. At the same time,
the role of health care providers is imperative in the educa-
tion and awareness of the general population. Health care
providers can carry out a longitudinal process of educating
the population at primary, secondary as well as tertiary
level of health care. Target groups for specific populations
could be made and their specific issues could be addressed
by the government or NGOs such as providing awareness
of antenatal health care interventions to women of the
reproductive age group in the community. Such measures
would ensure the maximum reach and awareness and
enable effective education of the general population.
Evaluation
Once these health care packages are provided to people,
the impact should be evaluated. This would help in identi-
fying areas of improvement and thus overcome the defi-
ciencies of implementation strategies. Small pilot programs
can also be conducted to better understand the needs and
focus health care provision according to the requirements.
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It is important to address the specific needs of the commu-
nity. Many a times, interventions have to be delivered in a
way most suitable to the community. At the same time,
factors that are hindering the delivery of the interventions
need to be addressed e.g. the provision of safe abortions
should be advocated particularly in community of sex
workers. Hence implementation should match the needs of
the community.
Figure 2 Implementation strategies for delivery of the proposed health care package
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Conclusion
This review was designed to serve as a comprehensive
and thorough document of essential RMNCH interven-
tions which could be used by both clinicians and policy
makers. The implementation of these interventions with
suggested strategies is a combined responsibility of both
the public and private health sector and requires a con-
certed and well planned effort. Working in synergy of
both these group including the NGOs contributing to
the health sector would ensure maximum implementa-
tion within a relatively short frame of time. These inter-
ventions should be integrated in health policies and
programs as part of a continuum of care approach. The
integration of these essential maternal and newborn
health strategies has the potential to improve efficiency,
save scarce resources, and ultimately improve maternal
and newborn outcomes. Implementation of these inter-
ventions will help reduce the mortality rates in areas
where maternal, neonatal and child mortality rates
remain high due to lack of specific interventions. This
also requires health system to adapt to these needs and
optimize the benefits of these interventions to the com-
munity by introducing policies which help in the imple-
mentation of these interventions. Funds need to be
allocated to obtain the commodities which are essential
for the delivery of these interventions. This approach is
critical to achieving MDGs 4 and 5 – ensuring that we
not only save lives but also to address overall health and
well-being.
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